Skip to main content
Figure 1 | BMC Musculoskeletal Disorders

Figure 1

From: Allogeneic blood transfusion and prognosis following total hip replacement: a population-based follow up study

Figure 1

Crude and adjusted odds ratios of adverse outcomes within 90 days of primary total hip replacement (THR) associated with red blood cell transfusion among propensity score matched patients. Submitted and labelled separately. Legend: * odds ratio with 95% confidence interval. ** odds ratio adjusted for haemoglobin concentration 1-7 days postoperative. Reference group is non-transfused patients.

Back to article page